Investing Profile

Nancy Hong

InvestorVC
Board Member at San Diego Symphony
Photo of Nancy Hong, San Diego Symphony

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
IT CRUX Mobile Apps Solutions Network
397 CONNECTIONS
University of California, Berkeley Network
362 CONNECTIONS
University of California, San Diego Network
47 CONNECTIONS
UC San Diego Network
37 CONNECTIONS
Caltech Network
21 CONNECTIONS
cb
$100K - $10.0M
$1M
9
CompanyStageDateRound SizeTotal Raised
Biolinq
Series CMar 2025$100M
Series BNov 2021$100M
$200M
Bluejay Therapeutics
Series CMay 2024$180M
Series BAug 2022$41M
$220M
Co-investors: Daniel Estes (Frazier Healthcare Partners)
Scout Bio
Series BOct 2021$33M
Series BApr 2019$20M
$53M
SeQure Dx
Series AApr 2021$18M
$18M
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$300M
Co-investors: Jack Kenney (SV Health Investors)
Board Member San Diego Symphony2021 - Present
Biotech Consultant IT CRUX Mobile Apps SolutionsPresent
Board Member Biolinq2021 - 2023
Board Member Bluejay Therapeutics2021 - 2023
Board Member SeQure DX2021 - 2023
Board Member Scout Bio2019 - 2023
Managing Director RiverVest Venture Partners2016 - 2023
Board Member and Observer Xilio Therapeutics, Inc.2019 - 2021
Principal at BioMed Ventures BioMed Realty2015 - 2016
Senior Associate at BioMed Ventures BioMed Realty2013 - 2015
Biotech Consultant Independent2010 - 2013
Scientist GNF2009 - 2009
Senior Analyst Forward Ventures2007 - 2008
Senior Scientist Phenomix Corporation2002 - 2006
Caltech B.S. Biology
University of California, Berkeley Ph.D. Molecular and Cellular Biology
University of California, San Diego Postdoc Biology
University of California, San Francisco Postdoc Biology
UC San Diego Postdoc Biology
California Institute of Technology bachelors, bachelor of science biology
University of California - Berkeley doctorates, doctor of philosophy biology